The efficacy of calcifediol in renal osteodystrophy.

Suppr

超能文献

作者信息

Recker R, Schoenfeld P, Letteri J, Slatopolsky E, Goldsmith R, Brickman A

出版信息

Arch Intern Med. 1978 May 15;138 Spec No:857-63.

PMID:646574

Abstract

摘要

相似文献

The efficacy of calcifediol in renal osteodystrophy.

Arch Intern Med. 1978 May 15;138 Spec No:857-63.

[Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].

Nihon Jinzo Gakkai Shi. 1982 Jun;24(6):693-704.

[Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].

Rev Rhum Mal Osteoartic. 1981 Jul-Sep;48(7-9):535-41.

[Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].

Dtsch Med Wochenschr. 1973 Jul;98(28):1379-81.

Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.

Kidney Int. 1979 Feb;15(2):196-204. doi: 10.1038/ki.1979.25.

[1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].

J Urol Nephrol (Paris). 1974 Dec;80(12):981.

A model for clinical research studies of renal osteodystrophy in children.

Arch Intern Med. 1978 May 15;138 Spec No:866-8.

[Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].

Minerva Nefrol. 1980 Oct-Dec;27(4):631-3.

[Treatment with 1-alpha hydroxy vitamin D3 of bone disease in hemodialysis. Therapeutic results and complications].

Rev Clin Esp. 1980 Dec 15;159(5):317-22.

Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.

Ann Intern Med. 1981 Mar;94(3):404-5. doi: 10.7326/0003-4819-94-3-404.

引用本文的文献

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial.在一项初步随机临床试验中，缓释骨化二醇使血液透析患者的1,25 - 二羟维生素D正常化并预防了继发性甲状旁腺功能亢进的进展。

Am J Nephrol. 2025 Jun 4:1-11. doi: 10.1159/000546615.

The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.维生素 D 代谢物和类似物在慢性肾脏病治疗中的应用。

Endocrinol Metab Clin North Am. 2017 Dec;46(4):983-1007. doi: 10.1016/j.ecl.2017.07.008. Epub 2017 Sep 29.

Calcium absorption response to cholecalciferol supplementation in hemodialysis.血液透析患者补充胆钙化醇后钙吸收的反应。

Clin J Am Soc Nephrol. 2013 Jun;8(6):1003-8. doi: 10.2215/CJN.08610812. Epub 2013 Feb 14.

Vitamin D therapy in chronic kidney disease and end stage renal disease.维生素 D 治疗慢性肾脏病和终末期肾病。

Clin J Am Soc Nephrol. 2012 Feb;7(2):358-65. doi: 10.2215/CJN.04040411. Epub 2011 Dec 22.

Hyperparathyroid bone disease in chronic renal failure.慢性肾衰竭中的甲状旁腺功能亢进性骨病

Ulster Med J. 1985 Aug;54 Suppl(Suppl):S34-43.

Vitamin D deficient states. Pathophysiology and treatment.维生素D缺乏状态。病理生理学与治疗

West J Med. 1979 Oct;131(4):305-12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验